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ABSTRACT
Microfocal CT was used to image the pulmonary arterial (PA) tree in rodent models of pulmonalY hypertension (PH).
CT images were used to measure the aJierial tree diameter along the main a1terial trunk at several hydrostatic
intravascular pressures and cnlculate distensibility. High~resolutioll planar allgiographic iluaging was also used to
examine distal PA microstructure. Data on pulmonary artery trce morphology improves our understanding of vascular
remodeling and response to treatments. Angiotensin n (ATn) has been identified as a mediator of vasoconstriction and
proliferative mitotic function. ATII has been shown to promote vascular smooth muscle cell hypertrophy and
hyperplasia as well as stimulate synthesis of extracellular matri..-x proteins. Available ATII is targeted through angiotensin
converting enzyme inhibitors (ACE-Is). a method that has been used in animal modcls of PH to attenuate vascular
remodeling and decrease pulmonary vascular resistance. In this study, we used rat models of chronic hypoxia to induce
PH combined with partial left pulmonary artelY occlusion (arterial banding, PLPAO) to evaluate effects of tile ACE!,
captopril, on pulmonary vascular hemodynamic and morphology, Male Sprague Dawley rats were placed in hypoxia
(Fi02 0.1), "vith one group having underwent PLPAO threc days prior to the chronic hypoxia. After the twenty-first day
of hypoxia exposure. treatment \vas started with captopril (20 mg/kg/day) for an additional twenty-one days. At the
endpoint, lungs were excised and isolated to examine: pulmonlli), vascular resistance, ACE activity) pulmonary vessel
morphology and biomechanics. Hematocrit and RVJLV+septwll ratio was also measured. CT planar images showed less
vessel dropout· in rats treated with caplopril versus the non-treatment lungs. Distensibility data shows no change in rats
treated with captopril in both chronic hypoxia (CH) and CH \vith PLPAO (CH+PLPAO) models. Hemodynatn.ic
measurCl1lcnLs also show no change in the pulmonary vascular resistance with captopril treatrncnt in both CH and
CH+PLPAO,
Keywords: angiotensin, ACEI, microfocal CT, pulmonary hypertension, distensibility, planar angiogram) rat model
1, INTRODUCTION

Pediatric patients with congenital heart disease, specifically \vith left to right shunts, are known to develop pulmonary
hypertcnsion (PH). Repair of the shunt at a young age decreases the risk of developing pulmonary hypertension but there
are some patients that continue to develop elevated pulmonary vascular re:5istance.31. Some of these children have other
co-morbidities that predispose them to PH, such as prematurity or chronic lung disease, The pathologic changes that
occur in PH secondary to congenital heart disease are similar to changes that occur in idiopathic PH. Pathologically,
23 33
there is hypertrophy and h:yperplasia of the media and, in some cases, development of plexiform icsions • . In rat
models of PH with prolonged vasoconstriction caused by chronic hypoxic exposure there is stimulation of vascular
remodeling and extension of vascular smooth muscle cells in to more distal previously non-muscular arteries 2,6,25,33.

Medical Imaging 2010: Biomedical Applications in Molecular, Structural, and Functionai ImagIng,
edited by Robert C. Molthen. John B. Weaver, Proc. of SP1E Vol. 7626, 762614· © 2010 SPfE
code: 1605~7422f10/$18 . doi: 10.1117/12.846387

eee

Proc. of SPIE Vol. 7626 762614-1

Though the causes of PH are not fully known, hypoxia, inflammation, and endothelial injury are all known stimuli for
the vasoconstriction and vascular remodeling that occurs in PH. Vasocons.lriction occurs due to 3n imbalance' between
vasoconstrictor and vasodilator mediators in the pulmonary vascular bed lO. There is a decrease in vasodilators, nitric
oxide and prostocyclin, and an inc.rease in vasoconstrictors, endothelin- l, and thromboxane AI. Prolonged
vasoconstriction leads to vascular remode ling, w hich is m ost ly irreversible, as we know it. Current therapies often aim to
change the balance between vasoactive mediators such as endothel in- l antagonists, prostocycli~ and nitric oxide.
Although these therapies s low the progression of the disease, they do not reverse it. Some studies have looked at the
mediators involved in vascular remo<ielillg ll ,It>. 21 .J 4 and -the. effects of modulating mediators to attenuate vascular
remodeling. One such mediator is angiotensiu II.
Angiotensin II (ATIl) has many effects on the vasculature. The two main A TIl mechanisms involve vasoconstricti ve and
mitogenic activity. /\. TIT is cr~ated by an enzymatic conversion of angiotensin I by angiotensin converting enzyme
(ACE), which is primarily fOllnd in the lung. ACE has bee,ll shown to reduce vasod ilatation by inactivation of
bradykinin ". ATII promotes s mooth muscle cell hypertrophy, hyperplasia and migration to the non-muscular pulmonary
vasculaturc4,1 t. Expression of ACE has been shown to increm;c after exposure to C1-eo. Angiotensin converting enzyme
inhibitor.; (A<:'Els) d ecrease available ATII . Studies have been done to examine lhe e llect of ACEI, on the development
of increased pulmonary vascul ar resistance. ACEls modulate vascular remodeling and decreases pulmonary vascular
resistance that occ urs in chronic hypoxia~·I:!:.22,26. Ho\-vever, previous studi es have started ACEl treatment prior 10 or at
the same time the stimuiuscausing PH and vascular remodeling (i.e. hypoxia or mOllocrotaline) was applied. This is a
preventative model of PH and cannot be u5cd to infer treatment benetits in patients with established pulmonary
hypert~nsion. Studies that have started therapy w ith an ACEl after establishment of pulmonary hypertension have mixed
results: with some showing a beneficial decrease in pulmonary vascular resistance and others ~hO\ving no benefie· 15.~:!.
Along with the d istal extension of smooth muscle celLo; irito non-muscular arteries and hyperplasia of the arterial media
layer, studies have shown evidence of raTefactions and loss of a.rterioles6.'8,24~ which is thought to be an important
component of PH. Other evidence of angiogenesis in thesystemjc vasculature in rats exposed to CH8,Q,JI may not be
reflective of what is OCCUlTing in the puhnonruy vascular bed, although recent study by Howell et a1. shO\ved that rat
exposed to CH have· increased blood vessel vo lume and length as well as increase capillary surface area9 • Results from
imaging experiments in this study provi de further evidence of vessel rarefaction with chronic hypoxia induted PH.

2. STUDY DESIGN
This study was d esif,'llcd to examine the effect of an orally ingested angiotensin converting enzyme inhibitor (captopril)
on the pulmonary vasculature in rats with established pulmonary hypc-rtension. Toward this goal \\'e utilized male
sprague dawley rats weighing 250-300gm ill two models of PH, one of chronic hypoxic (CH) expos ure and a second of
CH exposure after partial left. pulmonary artery banding. The Institutional Animal Care and Use Committee o f the
Zablocki V A Medical Center approved all protocols and procedures. In both the CH group (N ~ 8) and the CH +
banding group (N = 8), half of the rats recei ved treatment w ith captopril alter the first 2 I -days of exposure. A control
group had partial left pulmonary artery banding, was ke.pt in normoxia, and did not receive captopri l (N = 4).
2.1 Hypoxia
Hypoxia chambe rs had a FiO, of 0.1 , which was achieved by blending room air with N,. The FiO, was monitored and
maintainc-d for constant Fi02 at least twice daily. The rats were kept in the chamber except for food, water, weighing,
and bedding and cage changes twice \vcckly. These maintenance routines took under 30 minutes to complete and all rats,
except for the nonnoxics, were kept in CH for a total of 42-days.

2.2 Partial LeIt Pulmonary Artery Occlusion
Some rats underwent surgi cal partial Icft pulmonary artery occlusion (PLPAO) 3 days prior to placement in hypox ia
chambers (N ,_. S). The rats Were anesthetizcd with a ,"bcutaneous injection of ketamine (75 mglkg) and dormitor
(O.5mg/kg). They were weighed and, once a sufficient plane of anesthesia was obtained, intubated with a 14 gnuge
angine.th. placed on a ventilator (Harvard Apparatus model [nspira asv model# 55-7059) and ventilated with a peak
pressure of 32 cmH,O, peep of 7 cmH,O, and an initial rate of 72 breaths/minute. The chest was opened at the fourth
intercostal space and the left lung dellated. ntC left p ulmonary artery was identified and dissected away from the airway
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and partially occluded us ing a loop of ny lon suture around the artery. The lung was re-inflated by using s igh breaths of
40 cmHzO peak pressure. _When the lung was fu lly fe-inflated the chest was closed in two layers using nylon sutllre.
During skin closure each rat 'was given lOmg/kg of BaytrH subcutanoous ly and Antiscdan (l mg/kg) by intraperitoneal
injection, When the rat began to spontaneously breath at a regular rate, the endotracheal tube was removed, They were
placed on a heating pad, given 2ml of normal saline subculaneously and O,l-O'smg of Buprenex subcutaneously and
were allowed to recover.
2,J Cllptopri!
The rats that received treatment with an ACEI were provided eaptopril (20mg/kg/day) in their drinking water, starting
the 22nd day of eH exposure,

2.4 Endpoint Studies
Endpoint sUidies (day 42) included measurements ufhematocrit, body weight, RV/LV+scpturn ratio, FAPGG, dry lung
weight. hemodynamics) and micro-CT imaging 10 measure distensibility. diameter, and the length of the main pulmonary
tnmk,
Each rat was anesthetized wilh sod ium pentobarbital (40 mg/kg ip) and a midline sternolomy was performed, The cal
was heparini<ed (200 lUlkg) by right ventricular inj ection, and a blood sample was removed for hematocrit
determination. The trachea and pulmonary artery were cannulated, and the heart was cAc-ised for right ventricular free
wall and lefl ventricle plus septwn weight dClcnninatlon. The lung was ventilated with a 15% 02~ 6 % CO 2 in N2 gas
mixture,3 mmHg end expiratoty prc-ssure and 8 mmHg end inspiratory pressure, The. lung was subjected to 2 or 3 brief
peak inspirato ry episodes of 12- 15 mmHg to eliminate any atelectasis that might have occurred during the cx<:ision.
The lung was rinsed free of blood and perfused with a 37t:'c physiological salt solution containing 5% bovine senlDl

alburnin.
2,4,1 Hcmatoclit, RV ILV

+ septum Rotio, and HelDodynamics

Blood drawn H:om the heart was centrifuged at 30,000 rpm for alleasl 2 minutes and the ratio of packed cells to plasma
was Lt~cd to detemline hematocrit. Two samples were prepared from each rat and the average value reported, The heart
was excised and the right ventricle was dissected ii'om the left ventricle and ventricular septum. Each was weigbed and
tllC ratio was used to indicate rigbt ventricl~ar hypertrophy (RVH), A recirculation circuit was created with the excised
lung with the physiologic saline solution with 5% bovine serum albumin. Hemodynamic studies were performed by
measuring the puhnonary artery pressure at several flow rates from 0 to 40mllmin while maintaining a constant airway
pressure of 6 mmHg. The flow was normalized to rat body weight for graphical analysis,

2,4,2FAPGG
N-[3 -(2-furyl)-acryloIJ-L-phenyl-alanyglyclglycine (FAPGCi) is an ACE subs Irate u,ed to determine the activity of
ACE, FAPGG is hydrolyzed to PAP and there is a resultant decrease in absorbance. at 340nmlli. FArGG is perfused
through the IWlg for 50 sec then samples of the effluent arc obtained at 55 and 60 sec fo r the full lung, The effluent
samples. were placed in a spectrometer and the absorbance measured and used <!s and indicator of the binding activity of
ACE. ACE activ ity is presented as means surface area product (MSAP),

2.4,3 Mlcrol'oca[ Angiography and CT Imaging sud Analysis
The lung was immediately placed in the imaging chamber and ventilated v.ith the gas mixture listed above, An
n.~servoir of pcrt1uorooctyl bromide lPFOB), an X-ray contrast agent, was connected to the pulmonary
artery cannuL1 via clamped 118 inch ID Tygon ulbing. The tubing was undamped and th e physiologic saline soluti on in
the lung was then replaced by PF03, Because, PFOB does not pass tbrollgh the capillary bed, it only fills the
pulmonary arterial tree and intravascu lar pressures can be maintained hydrostatically. Accounting for the density of the
PFOB, intravascu lar pressure was determined by measuring Ihe d ifference between the height of the surface of PFOB in
the reservoir and the center of the lung. The arteries were conditioned by cycling the intravascular pressure from 0 to 30
mmHg several times. Ventilation was halted during imaging, airway pressure was again maintained constant at 6 mmHg.
The arterial pressure was sct to 30 mmHg, and the lungs were rotated in the x-ray beam of a custom built microfocal

atmosphcriL-:
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imaging system l4.l 8 at 1(' increments to obtain 360 planar images. The pressure was lowered successively to 21, 12, and 6
mmHg, \vith complete CT scans obtained at each presslrre {see Figure 4). Each scan took approximately 3 minutes. The
lungs we·re then translated tmvard the· X-ray source and high-magnification planar images of each lung lobe were
obtained at each intravascular pressure.
Arterial distensibili ty was measured using previo usly published methods30 . Drietly~ isotropic CT volumes of the isolated
lungs wert:: obtained at each. of the four intravascu lar pressures. A Visualizatioll JVorksho{J (A VW ~ Analyze® Biomedical
Imaging Resource (BIR) {It the Aiu}'o Cliflic17,?~,29 was used ·to segment and map the main pulmonary trunk. Consecutive
2-dimensional orthogonal planes along the main pulmonary trunk were then fit to a modified Guassian function, by a
process of two-stage numeric optimization. The vessel diameter estimation was performed using a technique of
multidimensional, constrained non-linear least squares titting and a. variant of the Levenberg-Marquardt least squares
l7
minimization implemented by Manolis Lourakis was used under the tenus of the GNU 'General Public Liccns~3. To
estimate artetial dis tens ibility~ the data were tit to a morplu:mlctric model of ihe pulmonary arterial tree, wh.ich
incorporates a well-accepted model of pul monary anerial distensibiHty using lite unconstmined mul tivariable nOD-linear
optimization function ' tin inw)c' in the Matlab optimization toolbox (MathWorks. Natick, MA).

3. RESULTS
Statisticsal significance was determined by performing paired t-test and a one way ANOV A and a1l1fraphs plot mean
values with standard error bars. CI-I significantly increased the hematocrit, however, there was no significant diffL'I"CnCC
in hematocrit levels in rats treated with capropril and those provided only water. Hematocrit in CH and CH+PLPAO
groups was not significantly different ,vith and without captopril treatment. However, there is a statistically significant
difference be·"h¥e~n the hematocrit of the PLPAO nomloxic group and all the other groups, p<O.02S. Hypoxia is a
significant stimulus for red blood cell production and captopril treatment did not a lter the stimulus effect.
ACE activity was inhibited in the rats that were treated with captorpil, confimled by the decreased mean surface area
],roduct in treated rats. The ACE activity was not significantly different in the CH, CH+PLPAO. and PLPAO normoxic
rats that did not rcc c i\',"~ captopril treatme,nt.
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(!'igure 2. 1'ot21 Lung ACE ActiYity

Figu re 1. Hematocrit
Bars rcpn'S{'iIt tnt! mean Hilue q{ht'matocrit in Cf{·". PlPA().
eH 1 PLPAO w/ captoplil. ('fl, elf w/ captopri! and PLPAO
lVol7lw:da. En-or bars are ~ s([Jndard en·or. "f>/J ":: 0.025

/Jars represem the meal! value (Jfrm,~/ IUllg ACE actil-ity as meall
slIr/ace area product mea.mred in iso/arM JUIIg.tj;·om (1{-PLPAO.
CH+PLP.40 jot.;! captopl'll. CN. ell wi captoprii. mid PLPAO NOf7lloxia
r.1lS. F.n·or bars arc ±Sf<llItfard error . f<p < 0.00 .1
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Rals in Ihe CH and CH+PLPAO groups (whelher trealed
or nOI) had significantly increased RVH compared 10
PLPAO nonnoxic rats as seen in Figure 3 with a
p<O.OO l. A hhough there was a tendency to ward a
further increase in RVH. the RVI LV + Septum mass
ratio was not statistic,ally significantly different betw~n
the CH and (,H~ PLPAO groups. This is an ind icalor

that the in vivo pulmonary vascular resistance likely
remained elevated in rats treated with captopril.
pulmo nary pressum versus flu\v data below supports
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The lung hemodynamic data is presented in Figure 4.
The main pulmonary artory pressures measured at the
various flow rates are graphed with flow normalized to

- - -- _._._._.-

body weight, Tile PA pressure is significantly increased

Figure 3. Righi: Venlyicular Hypertrophy

in lhc CH and CH+PLPAO lrealmenl and non-LreaLmenl
groups compared to normo:x;ia, as expected. However.
Figure 4 shows no significance-di fference in pulmonary
vasclllat resistance of any o f the ell animals, whetber
with or wi thout PLPAO or with or without c.apt opriL
Treatment w ith capropril did not lower the pulmonary
vascular resistance and the pressure obtained for a given
flow r<:mains elevated to a comparable level in the
treatme nt groups.

Rig hI Ventricular l1.lpertroph)' is (':rprt~.'i~'{'d (IS the RVILV+Sl'PIUnI ratio.
Bars repreS(?f!( the mealll'O/lles in CH +/'LPAO. Cll+PLPAO wi
;:.'1plopril. CH. CH wi captopril, ttlld PI.PAO IItJl1lloxia, Error barJ ar~ ±
slamumJ error, Qp< O,OOl

Full Lung
18

- " ' PLPAO Normoxia
- · -CII
-

- CH w/ Captopril
·· .. ··CH+PLPAO
--ClI+PLPAO wi Captopri l

o

60
"')0\0\'

80

1'JO

120

(mllkglmin)
"~igure 4.

Uemodynamics of Full LWlg

Flo w is normalized ;0 rai body weighlllnd is in ul/its of mllkg/mill and pressl!re i ... in mmHg, Erro,' bars are
sfwuiard ('/'I'ur
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Planar angiograms of the contrast filled arteries from selected lungs from each group arc presented-in Figures 5 and 6.
These images were obtained from the highest (30 mmHg) and lowest (6 mmHg) intravascular pressures measured.
The images of both treated and non-treated groups shmv fe'wer peripheral vessels than the 'PLPAO rats kept in norrnoxia.
However, the rats treate.d with captopril had less vessel dropout than those that did not receive treatment. This pattero of
vesseJ dropout was mOTe apparent at the higher intravascular pressure 30 mmHg (Figure 6). Th e images also show slight
apparent parenchymal edema in the CH and CH+PLPAO groups compared to the PLl'AO Ilormoxic group. The edema
appeared more exagge.raccd in the hmgs of ra ts treated with captopril compared to untreated.

Figure 5. Low-Magnification Imagcs of Fun Lung at 6 mmHg
Scale iJlllpper right I'p.pl'e.wmts I. 7mm. Arrow llldicfl/(,s area ofPlPAO
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Figure 6. Low-Mngnmcation Images of Full Lung at 30 mmHg
Scale ill upper r ig hllvpr'f:'Sellt5 I. 7f11m.. An'ow illdit'ares area ofPLPAO

High-magniti.cation planar angiograms of the distal right arterial tree, presented in Figures 7 and 8. reveal more evidence
of the vessel dropout in hath CH and CH+PLPAO groups compared to the norrnoxic PLPAO rats. Again, the images
suggest that there is less parenchymaJ vessel dropout ill the treatment groups, in particular rats with CH+PLPAO and
c(lplOprii treatment. I.n ge-neral. there appeared to he Jess dropout in the CH+PLPAO rats compared to exposed to en
\\rilhout the banding.
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Figure 7. High Ma.gni.ficratlon of the_Right Lun,g at 6 mmHg
Scale bal' repro:wems 500W1l

Figure. 8. High Magnific:lticD of dle Right Lung at 30 mmHg
SCdle bm" represents 500/fllt
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Figure 9 shows data from the main right pulmonary arterial trunk measured in micro focal CT inlages for a selected lung.
The graph presents vessel diameter versus the distance from the arterial inlet, at four intravascular pressures. The grey
surface represents the fit t{> the morphological model 19 and the tilt of the surface along the pressure axis reflects the
anerial distensibility.

Figure 9. Principal pathway data for a scltcted lung

The morphologic model is given in by Eq. 1 belo'w, where D(x,P) represents the vessel diameter, x is the distance ITom
the inlet, P is the intravascular pressure, D(O,O) is the unstressed diameter of the inlet, a is a distensibility coefficient, c
is a measure· of the taper of the main tmnk, and LInt is the total length of the main trunk 1OJ,

D(x,P) '" D(O,O)(l + aPJ.l_--=-)'·
'\.

L tot

Eq. (I)

Morphologic data is shown in Table I. This data indicates distensibility (a) was unchanged by captopril treatment. The
pulmonary artery inlet diameter,D(O,O)) and the total length ofthc pHlmonaPJ lnmk.,Ltub were not diff(~rcnt between
captopril treated and non-treated rats.

CH+PLPAO

eH

CH wI capt9pril

CH+PLI'AO

(n - 3)

(n = 2)

(n - 4)

captopril
in =--, 4)

No.
Vessels
Measured

445 ± 13

408 ± 1

409±9

389 ± 10

0(0,0) (mm)

1.73± 0.19

1.75 ± 0.33

1.86 ± 0.14

1.806 ± 0.232

Ltot(mm}

55 ± 1

53 ± 1

53 ± 1

53", 1

a (1/mmHg)

0.017 ± 0.002

0.012 ± 0.0008

0.012 ± 0.003

0.017 ± 0.003

wi

Table 1. Morphometric Data. No of vessel segments along the main pulmonary trunk used: jn the analysis, D(O~O) is the
unstressed vessel diame tc~ at the ar terial trunk in ~ et, Ltot is the total length ofthe main trunk, and a is the artcriaj tree
dist!;!nsibHity.
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4. DISCUSSION
There are few studies evaluating the effect of ACEI on vascular remodeling in a rat model of established pulmonary
hypertension LB.::' Z. Previous stucties, in which PH is already established, have shown mixed hemodynamic changes with
ACE' treannent. Nong ct al. showed thai Ireatment with ACE! (quinapril) in established PH did reduce lhe pulmonary
artery prcsstU'c and degree nfvascular rcmodd ing22, while Clozel et a1. showe.d a decrease- in pulmonary artery pressure
and hematocrit with treatment with cilazapril'. Jeffery ct al. showed mixed eiTects based on the dose ofperindopril with
higher doses causing a slight reduction in pulmonary artery pressures u . This srudyis unique in thaI' we used CT imaging
techniques to further interpret the hemodynamic data obtained. Thc C 1" images were, used to quantify morphology and
biomechanics in the pulmonary arterial tree. The planar images, in conjunction \vith the morphometric data. provide a
picture of practically tixcd dis1ensibility between treatment and non-treatment groups with less vessel dropout
peripherally in the treatment groups. The high-rnagnitication planar angiograms indicate les& vessel dropout in the
tre·atment groups versus the non-treatment groups, which may be mitigation or a change in the evolution ,of vElscular
remodeling. This would suggest that there should be less elevation in the PVR of the rats treated with captopril.
Ho.wever, our hemodynamic and right ventricular hypertrophy data is contrary and shows no dilTerence in PVR or RVH
between treated and non-treated rats. The morphologic. anatysis shows no statistically significant differences in diameter,
length, or distensibility belween the rats lhat received c.ptopril and those that did not. These result, imply lhal altho ugh
there are more arterial vessels present in the caplopril trealed lungs, Ihe newlOrk of vessels present have a larger PVR.
This increase in PVR could be, in part. explaiD<.·d by the increased secondary parcnc.h yrnal ed~ma present in the captopril
treated rats. This would be especiaJly the ('·ase in vivo given the high hematoc·r it levels seen in these animals]". The
increase in parenchymal edema results in stitT and less compliant lungs. whicb may translate to the persistent elevation in
PVR de~pite more peripheral vessels. Interes(ingly~ L,O! was not was increased with captopril treatment. If anything. the
CT data suggests the CH group tended to have a longer tmnk len!,'lh. These findings most likely indicate that any
dongation is occ.urring in the larger vessel. Because uur current analysis relies on detecti on of a single main tnmk,
evaluation of peripheral density is not adequately represented by It(lt.
The CH+PLPAO model was used to simulate the increased flow that is seen in pediatric patients with congenital heart
disease. There is no statistically significant ditTerellce. in the me.asured arterial distensibility between CH and
CH+PLPAO with or vlithOllt treatment, but the hcmodynamk,s show a trend toward higher PA pressures in the
CH+PLPAO groups as well as a trend toward a higher degree of RVH. This suggests thai CH+PLPAO results in a
higher in vivo PA pressure or there is hematopoietic or other signaling that results from the PLPAO banding, Increased
flow and shear stress, causing more endothelial injury, may be a dependent factor that atTects the condition of the right
heart. This relati onship would nocd to be further evaluated with additional studies,
CT angiography in models of lung disease in small animals described by Shingrani ct al'" and Molthen et .1 " is a
relatively new method tor. assessing (he pulmonary vascu lar tree. Imaging of (he vascular bed allows for morphometric
and biomechanical information 10 be obtained, which can tben be used in conjunction wilh biochemical studies to further
utilor ·lhcrapies. Although captopril did not have a net beneficial effect on hemodynamics of the pulmonary vasculature
in thi s s1udy. ACEI treatment did afl'ect the vascular morphology of the· pulmonary arterial bed. This suggests that
although c::1ptopril by itself may not provide a benefit to pulmonary hemodynamics, its use in altering the vcssel
morphology may be through combinational therapies.

5. REFERENCES
1. Clozel lP, Salmier C. Hartemann D, Fischli Vv': Effects of cilazapril, a novel angiotensin converting enzyme, inhibitor.
on the :\tl1lcture ofpulmonaty artelics ofra1s exposed 'to chronic hypoxia. J Cardiovasc Pharmacol 1.99l , 17(1):36-40.
2. Diller GP, Gatzoulis MA: Pulmonary vascular diseast! in adults with congenital heart disease. Circulation 2007.
115(8):1039- 1050.
3. GN U General Public License, unspedtied, http: //www.gnu.orglcopyleft/gpl.html
4. Hcencman S~ Sluimer JC, Daemen MJ: Angiotensin·converting enzyme and vascular remodeling. Cire Res 2007.
101(5):441-454.
5. Herget J, Pelouch V, Kolar F, Ostadal B: The inhibition of angiotensin converling enzyme attenuates the effects of
duonie hypoxia on pulmonary blood vessels in the rat. Physiol Res 1996,45(3):221-226.

Proc. of SPtE Vol. 7626 762614-10

6. Hislop A, Reid l: New findings in pulmonary arteries of rats wilb hypoxia-induced pulmona,y hypertension. Br J Exp
Pathol 1976, 57(568):542-554.
7. Holmquist B, DUMing P, Riordan JF: A continuous spec.trophotometnc assay for angiotensin convcrling enzyme.
Anal Biochem 1979, 95(2):540-548.

8. Hopkins N, McLoughlin P: The· structural basis of pulmonary hypertension in chronic lung disease: remodell.ing,
raref,clion or angiogenes is? J Anar 2002, 201(4 ):335-348.
~).

Howell K, Preston RJ, McLoughlin P: Chronic hypoxia causes angiogenesis in addition to remode.Uing in the adult rat

pulmonary circulation. J Physial 2003, 547(Pr I): 133-145 .
10. Humbert M, Morrell NW, Archer SL, Stenmark KR, Maclean MR, Lang 1M, Chlistman BW, Weir EK, Eickelberg
0, Voelkel NF, Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coli
Cardiol2004, 43(12 Suppl Sl: 13S-24S .
.II. Jeffery TK. Wanstall JC: Pulmonary vascular remodelillg: a target for therapeutic intervention in pulmonary
hypeneosion. Ph.rm.c.ol Ther 200 I, 92( I): 1-20.
12. Jeffery TK, \OVanstall JC: Pulmonary vascular remodelling in hypoxic rats: effects '-If amlodipinc, alone and with
p.rindopri!. Eur J Pharmacol200 1, 416(1-2):123-131.
13. Jeffery TK. \Vanstall JC: Perindopril, an angiotensin converti ng enzyme inhibitor. in pulmonary hypertensive rats:
comparative elTeeLS on pulmonarj vascular struenlfe and fUllction. Sr J Pharmaeol 1999, 128(7): 1407-1 418.
14 . Karau KL. Johnson RH. Molthen RC, Dhyani AB, Hawolll! ST, Hanger ce, Roerig DL, Dawson CA: Microfocal Xray CT imaging and pulmonary arterial distensibility in excised rat loogs. Am J Physiol Heart Circ Physiol 2001,
281(3):H 1447-57
15. Leier CV. Bambach 0, Nelson S, Hermillcr JB. Huss P, Magorie.r. RD, Unverfertlt DV: Captop, il in primary
pulmonary hypenension. Circulation 1983, 67(1): 155-161.
16. li M, Zhou TF, Liu HM, Hua YM, Wang XM: Elleet of captopril on pulmonary vascular remodeling induced by
Icft-IO-right shunt in rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2006, 37(2):242-245.
17. M.l.1\. Lourakis. Levmar: Levenberg-Marquardt nonlinear least squares algorithms in C/C++. 2004,

http://www. ics.forth.gr/-!ourakis/levmal
IS. Meyrick B, Reid L: The clrec! of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study.
Lab Invest 1978. 38(2):188-200.
19. Molth.n RC, Karau KL, Dawson CA: Quantitarive models of the rat pulmonary allcrial tree morphometry applied to
hypoxia-induced arterial remodeling. J Appl Physiol2004, 97(6):2372-84: discussion 2354.

20. Morrell NW. Atochina EN, Morris KG, Danilov SM, Stenmark KR: Angiotensin converting en7yme expression is
incrc~iScd in small pulmonary arteries of rJ.ts with hypoxia-induced pulmonary hypertension. J e lin lovest 1995,
96(4): 1823-1 R33.

21. Morrell

NW~

l\'lorris KG, Stenmark KR: Role of angiotensin-converting enzyme and angiotensin 11 in development

ofhypoxie pulmonary hypertension. Am J Physiol 1995,269(4 Pt 2):H 1186-94.
22. Nong Z, Stasserl JM, Moons L, Collen D, Janssens S: Inhibition of tissue angiotensin-converting enzyme with
qu inapril reduces hypoxic pulmonary hype.rtension and pulmonary "aseular remodeling. Circulation 1996, 94(8): 19411947.
23. Rabinovitch M FAU - Gamble, IN, Gamble W FAU - Nadas, A S, FAU NA, FAU MO, L R: Rat pulmonary
circulation after chronic hypoxia: hemodynamic and structural features. (0002-95\3):.
24. Rabinovitch M, Chesler N, Molthen RC: Point:Countcrpoint: Chronic hypoxia-induced pulmonary hypertension
does/does not lead to loss of pulmonary vasculatwe. J Appl Physiol 2007, I 03(4): 1449-1451.
25. Rabinovitch M, Haworth SO, Castaneda A~ Nadas AS, Reid LM: LlU1g biopsy in congenital heart disease: a

morphometric approach to pulmonary vascular disease. Circulation 1978, 58(6): 1107-1122.

26. Rllk.ugi H, Kim DK, Krieger .TE, \-Vang DS, Dzau VJ, Pratt RE: Induction of angiotensin converting en:lyme in the
neointima after vascular injury. Possible role in restcnosis. J Clin Invest 1994.93(1 ):339-346.
27. Robb RA. Hanson DP, Kalwoski RA, Larson AG, Workman EL, Stacy MC: ANALYZE: A comprehensive,
operator-interactive software package for multidimensional medical image display and analysis. Computerized ~,.1e.dic·a l
Imaging and Graphics 1989, 13 :433454.
28. Robb RA, Barillot C: Interactive display and analysis of 3-D medical Images. IEEE Transactions on Medical
Imaging 1989,8(3):217-226
29. Robb R.A: The biomedical imaging resolltcc at Mayo Clinic. IEEE Transactions on Medical Imaging 200 1,
20(9):854-867

Proc. of SPtE Vol. 7626 762614-11

30. Shingrani R~ Krenz G, Molthen R: Automation process for morphometric analysis of volumetric CT data from
puhllonary vasculature in rats. Comput Methods Programs Biomed 2009, .
31. Smith K, Marshall J1vt Physiological adjustments and arteriolar remodelling \Yithin skeletal muscle during
acclimation to chronic hypoxia in the rat. J Physio] t 999,521 Pt 1:261-272.
32. Steinhorn RH~ Fineman JR: The paLhophysiology of pulmonaI)T hypertension in congenital heart disease. Atiif
Organs 1999, 23(\ I ):970-974.
33. "fulloh RM: Congenital heart disease in relation to pulmonary hypertension in paediatric practice. Paediatr Respir
Rev 2005, 6(3):174-180.
34. van Suylc-n RJ~ Aarlscn \VM, Smits JF. Daemcn MJ: Dissociation of pulmonary vascular remodeling and right
ventricular pressure in tissue an.giotcnsin-eonvclting enzyme-deficient miee under conditions of chronic alveolar
hypoxia. Am J Respir Crit Care Med 2001,163(5):1241-1245.
35. Wang CG, Hakim TS, 1\1ichel RP, Chang HK: Segmental pulmonary vascular resistance in progressive hydrostatic
and permeability edema. J App1 Physio] 1985, 59(1 ):242-247.

Proe. of SPIE Vol. 7626 762614-12

